Ready Med Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.3/10
Best for: a low first month of compounded semaglutide with a required live video visit
Ready Med scores below our bar on medical oversight. Read the score breakdown before signing up.
Semaglutide
then $199/mo ongoing
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Ready Med (Medical Weight Loss Center, Clearwater, Florida) offers compounded semaglutide and tirzepatide after a required video visit, with medication, the visit and shipping in one monthly price. Semaglutide is $99 the first month, then $199 a month, and tirzepatide is $449 a month. The FDA sent Ready Med a warning letter in June 2026 over how its website describes these compounded drugs.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Ready Med
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Ready Med at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo (after intro offer) ($99 first month)
- What's included
- Medication · Consult · Shipping
- FDA status
- 1 FDA warning letter on record; see below
How we scored Ready Med
Each dimension is scored algorithmically from Ready Med’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
6.3/10At $199/mo (after intro offer), Ready Med runs about 8% above the $185 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide), with an intro price of $99.
Effectiveness25%
7.6/10Ready Med offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.6/10Online intake and platform experience (consult included in the price); 5 platform features disclosed.
Trust & Safety15%
4.8/10Core details confirmed by our editors; an FDA warning letter is on file (see flag above).
Accessibility10%
5.9/10Ready Med's exact state footprint isn't published. Confirm coverage in your state before signing up. Insurance pathways are offered for eligible patients.
Support10%
5.4/10Ready Med provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Ready Med review
Last checked November 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $199–$449/mo across 2 dose/plan tiers (checked November 2026)
- FDA warning-letter register
- An active letter is on file for this provider; see below
What to expect when you sign up with Ready Med
We walked Ready Med’s public signup flow in November 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1'Get Started' and 'Start Treatment Online' on the semaglutide and tirzepatide pages open a contact form asking for your name, email, phone and the service you want
- 2'Book Now' in the header opens a page about paying through Cherry financing rather than a booking calendar
- 3Ready Med says its team then schedules a video visit with a clinician on Doxy, and the prescription ships from a compounding pharmacy if approved
- Prices are on the treatment pages before you contact them, but the tirzepatide page shows both $297 and $449 a month
- The FAQ says every patient must have a video call with a provider before medication is sent
- Product pages promise a 30-day refund guarantee, while the terms say no refunds of any kind
- Contact is by phone or a Gmail address; the footer also links to social accounts belonging to a different telehealth company
Ready Med customer support
- Phone
- 866-287-5482
- Hours
- Monday to Saturday, 10:00 AM to 6:00 PM Eastern
GLP-1 medications Ready Med offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
'$99 FIRST month and then $199 EVERY month', medication included. The membership ships every 60 or 90 days; monthly shipments or higher doses (up to 2 mg a week) cost an extra $100 a month.
'The cost of your medication is included in your $449 per month membership.' The same page's banner also says 'Only $297 per month'; doses up to 12.5 mg a week cost an extra $100 a month.
Ready to get started?
Plans and promotions change often, so check Ready Med's current pricing and active discounts before you decide.
What we like
- Semaglutide starts at $99 for the first month, then $199 a month with medication included
- One monthly price covers the video visit, the medication and shipping
- Month to month with no long-term contract or cancellation fee
- Every patient has a live video visit with a clinician before anything is prescribed
- Phone support Monday to Saturday, 10am to 6pm Eastern
Watch-outs
- The FDA sent Ready Med a warning letter in June 2026 over misleading claims about its compounded semaglutide and tirzepatide
- The claims the FDA cited, such as 'the same active ingredient in Mounjaro and Zepbound', were still on its pages in November 2026
- Refund terms conflict: product pages promise a 30-day money-back guarantee, while its terms say it has a strict no-refund policy
- Tirzepatide pages list both $297 and $449 a month
- There is no online sign-up: 'Get Started' opens a contact form, and support runs through a Gmail address
- The dispensing pharmacy is not named, and the site does not list the states it serves
- The $199 semaglutide plan ships every 60 or 90 days; monthly shipments cost $100 more a month
Is Ready Med worth it?
What Ready Med is selling, in one line, is a low first month of compounded semaglutide with a required live video visit. New patients start at $99/month for the first month, but the price steps up to $199/month once that window ends, so treat the headline number as an intro offer, not the standing rate. No single feature of its GLP-1 program sets it apart from the category on its own, so the price and terms below are the things to compare.
Ready Med doesn't require insurance.
How much Ready Med costs
- Compounded semaglutide starts at $99 for the first month, then $199/month after that, if you go that route.
- Compounded tirzepatide runs $449/month (see plan details), at that tier.
Because Ready Med's headline figure is listed as “after intro offer”, we don't set it against the roughly $185 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare Ready Med with the month-to-month prices of the alternatives below instead.
Belle Health (about $199/month) is one of the closest alternatives to weigh Ready Med against.
Medications: what Ready Med prescribes
Ready Med prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two molecules with the strongest published weight-loss trial outcomes. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products, which is the standard trade-off across the compounded-GLP-1 market.
Who Ready Med is best for, and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program and are comfortable comparing it against the alternatives below.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
- want a provider with a clean regulatory record (note the FDA warning flagged at the top of this page).
Trust, safety, and medical oversight
It does have an FDA warning letter on file, which we flag at the top of this review; read it before starting. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
Ready Med's intro price of $99 takes some of the cost out of the first month, but plan around the $199/month standing price, since that is what you pay from then on. One important caveat: it has an FDA warning letter on file, so read it (flagged at the top of this review) and talk with a clinician before choosing it.
The Bottom Line
Ready Med scores below our bar on medical oversight. Read the score breakdown before signing up.
Ready to start with Ready Med?
From $199/mo (after intro offer). See current pricing and start your free consultation.
Ready Med might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Ready Med vs…
Ready Med scores6.3/10
Side-by-side pricing, medications and scores. Pick a matchup.
Ready Med vs Amazon One Medical
Amazon One Medical scores 8.5/10
Ready Med vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
Ready Med received an FDA warning letter dated June 8, 2026
The letter concerns false & misleading claims/misbranded (telehealth). FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity. Companies often respond with corrective action.
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Ready Med review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Ready Med's current pricing
Plans from $199/mo (after intro offer). Start your free consultation to check eligibility and today's price.